ClearSight, a leading provider of advanced vision correction solutions, is now offering the PanOptix® Trifocal Intraocular ...

Clareon Vivity is the first and only non-diffractive extended depth of focus (EDOF) IOL with the wavefront-shaping X-WAVE Technology on Alcon’s most advanced lens platform1-6 Clareon Vivity ...

Compared to an aspheric monofocal IOL, the lens provides improved intermediate ... of the Patient Information Brochure available from Alcon, informing them of possible risks and benefits ...

The Alcon survey found: Only 51% of individuals aged 50 and above are aware that they have various options for intraocular lenses (IOLs) to suit their specific needs. Just 58% of individuals aged ...

Alcon also has a suite of advanced-technology intraocular lenses, or ATIOLs, that go beyond correcting vision issues at one distance. Although today’s global ATIOL market penetration rate by ...

Alcon ALC recently received Food and Drug Administration (“FDA”) approval for its TRYPTYR (acoltremon ophthalmic solution) 0.003%. TRYPTYR is indicated for the treatment of the signs and symptoms of ...

Background: To evaluate the rotational stability of the three types of AcrySof SA60TT toric intraocular lenses (Alcon, Switzerland) in cataract surgery after the first postoperative week.

Alcon also has a suite of advanced-technology intraocular lenses, or ATIOLs, that go beyond correcting vision issues at one distance. Although today’s global ATIOL market penetration rate by ...

This is the very first Direct to Patient (DTP) campaign for an Intraocular Lens (IOL) Alcon has undertaken, and therefore there are no benchmarks or previous campaign learnings to leverage.